logo.png
XTL To Aquire The Social Proxy
March 20, 2024 10:15 ET | XTL Biopharmaceuticals Ltd.
expands its IP portfolio to AI Web Data The Social Proxy is a web data AI companydeveloping and powering an IP based platform for AI & BI Applications at scale Secured $1.5 Million in a...
logo.png
XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
October 20, 2023 16:00 ET | XTL Biopharmaceuticals Ltd.
Ramat Gan, Israel, Oct. 20, 2023 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB, TASE: XTLB.TA) ("XTL" or the "Company"), a clinical stage biopharmaceutical company whose main assets...
logo.png
XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in Israel
October 20, 2023 16:00 ET | XTL Biopharmaceuticals Ltd.
Ramat Gan, Israel, Oct. 20, 2023 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB, TASE: XTLB.TA) ("XTL" or the "Company"), a clinical stage biopharmaceutical company whose main assets...